Quinapril hydrochloride is a hydrochloride resulting from the reaction of equimolar amounts of quinapril and hydrogen chloride. A prodrug for quinaprilat hydrochloride (by hydrolysis of the ethyl ester to the corresponding carboxylic acid), it is used as an angiotensin-converting enzyme inhibitor (ACE inhibitor) for the treatment of hypertension and congestive heart failure. Among its listed roles, it functions as a antihypertensive agent and an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor. It includes a quinapril(1+). It is grouped under the following drug class(es): ACE Inhibitors. Its therapeutic use is listed as antihypertensives and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Accuprin and Korec. Its PubChem CID is 54891.
Quinapril hydrochloride
| CAS No | 82586-55-8 |
|---|---|
| Molecular Formula | C25H31ClN2O5 |
| Molecular Weight | 475.0 g/mol |
| Synonyms | (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Quinapril hydrochloride is a hydrochloride resulting from the reaction of equimolar amounts of quinapril and hydrogen chloride.
The listed CAS number is 82586-55-8.
The listed molecular formula is C25H31ClN2O5.
The listed molecular weight is 475.0 g/mol.
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride.
The source lists Accuprin and Korec.